Taking digoxin does not increase the risk of mortality, hospital admissions or incident nonfatal arrhythmia in patients with atrial fibrillation, according to a study published online in the European Heart Journal. Researchers analyzed data from the AFFIRM study and found no significant difference in rate of all-cause death between digoxin users and nonusers.
Study rejects link between digoxin, mortality risk in A-fib patients
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|